Kazumasa Matsumoto

Kitasato University — Japan

Medicine · Health Sciences

55h-index10.3kcitations376works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(140), Urinary and Genital Oncology Studies(99), Urological Disorders and Treatments(53), Prostate Cancer Treatment and Research(45), Prostate Cancer Diagnosis and Treatment(41)

Publications375 total

Current status and issues regarding genetic medicine after cancer gene panel testing in Japanese patients with metastatic prostate cancer
Molecular and Clinical Oncology·2025Open Access
External Validation of Population Pharmacokinetic Models for Unbound Cefazolin in Patients Receiving Prophylactic Dosing
Biological and Pharmaceutical Bulletin·2025Open Access
Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical Cystectomy
Cancers·2025Open Access
Metastatic pattern with mild prognostic impact in high-volume castration-sensitive prostate cancer
2025Open Access
Predictive Value of the Prostate-specific Antigen Doubling Time for the Effectiveness of Metastasis-directed Radiotherapy in Patients With Oligometastases After Radical Treatment for Non-metastatic Prostate Cancer
Cancer Diagnosis & Prognosis·2024· 1 citedOpen Access
Predictive Value of the Prostate-Specific Antigen Doubling Time for the Effectiveness of Metastasis-Directed Radiotherapy in Patients with Oligometastases after Radical Treatment for Non-metastatic Prostate Cancer: A Single Institution Retrospective Study
Research Square (Research Square)·2024Open Access
Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer
Japanese Journal of Clinical Oncology·2024· 2 cited
Effects of Cardiac Glycoside Digoxin on Dendritic Spines and Motor Learning Performance in Mice
Neuroscience·2024· 4 citedOpen Access
Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus
Journal of Infection and Chemotherapy·2024· 10 cited
The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy
Japanese Journal of Clinical Oncology·2023· 1 citedOpen Access
Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer
Diagnostics·2023· 1 citedOpen Access
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Data from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
2023Open Access
Data from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
2023Open Access
Sapplemental Table 1 from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
2023Open Access
Sapplemental Table 1 from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
2023Open Access
Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG
Cancers·2023· 6 citedOpen Access
Effects of cardiac glycoside digoxin on dendritic spines and motor learning performance in mice
Research Square (Research Square)·2023Open Access
Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study
Urologia Internationalis·2023· 3 citedOpen Access
Gemcitabine–Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
International Journal of Molecular Sciences·2022· 5 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Shahrokh F. Shariat(23), Pierre I. Karakiewicz(18), Wassim Kassouf(16), Giacomo Novara(15), Christian Seitz(13), Thomas J. Walton(12), Juan Ignacio Martínez‐Salamanca(10), Douglas S. Scherr(10), Yair Lotan(9), Vitaly Margulis(8), Jay D. Raman(8), Armin Pycha(8), Vincenzo Ficarra(8), Toshihiko Takada(7), K. Eugene(7), Francesco Montorsi(7), Stefan Tritschler(7), Patrick J. Bastian(7), Sadao Shiosaka(7), Koji Nomoto(6)